Truist Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Truist Financial’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,016	Closed	-$112K	–	2704
2022 Q3	$112K	Hold	50,016	–	–	﹤0.01%	2408
2022 Q2	$104K	Hold	50,016	–	–	﹤0.01%	2545
2022 Q1	$145K	Hold	50,016	–	–	﹤0.01%	2581
2021 Q4	$161K	Buy	+50,016	New	+$171K	﹤0.01%	2631

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Truist Financial's ENZ Position: Q4 2022 in Review

Truist Financial sold out of Enzo Biochem, Inc. (ENZ) in Q4 2022, closing a stake of 50,016 shares — an estimated $112K sold.

Truist Financial first reported a position in ENZ in Q4 2021 and held it in 4 quarters. The position peaked at $161K in Q4 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q4 2022.

Truist Financial reported no remaining Enzo Biochem, Inc. position as of Q4 2022 after selling out during the quarter.
Truist Financial sold 50,016 Enzo Biochem, Inc. shares in Q4 2022, an estimated $112K.
Truist Financial first reported a position in Enzo Biochem, Inc. in Q4 2021 and held it in 4 quarters.
Truist Financial's Enzo Biochem, Inc. position peaked at $161K in Q4 2021.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2022.

Based on Truist Financial's 13F filing for Q4 2022, filed 17 Feb 2023.